4G Clinical Nominated for Powerhouse Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards WELLESLEY, Mass. – October 14, 2021 – Today, 4G Clinical announced that it has been s... Read More › 14 Oct, 2021
A Metastatic Breast Cancer (MBC) Patient’s Journey to ‘No Active Disease’ The moment that Hannah Earle was diagnosed with breast cancer, she was holding a fuss... Read More › 15 Sep, 2021
Why the Pandemic is a Crucible for Clinical Trial Innovation September 13, 2021 Drug Discovery Trends Read More › 13 Sep, 2021
A Rare Disease Patient Sheds Light on Journey for Treatment 4G Clinical’s Senior Director of Marketing, Amy Ripston, had the opportunity to inter... Read More › 1 Sep, 2021
4G Clinical Ranks No. 111 on the 2021 Inc. 5000, With Three-Year Revenue Growth of 3,699 Percent Inc. Magazine Reveals Annual List of America’s Fastest-Growing Private Companies—the ... Read More › 17 Aug, 2021
Patient Choice Will Drive Adoption of Decentralized Clinical Trials August 6, 2021 The Association of Clinical Research Professionals Read More › 6 Aug, 2021
4G Clinical Raises $230M to Expand its RTSM Global Reach, Product Capabilities June 29, 2021 Fierce Biotech Read More › 29 Jun, 2021
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg? Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg? Read More › 30 Sep, 2020
Direct-to-Patient (DtP) in Review – What Would We Have Done Differently if We Knew COVID-19 was Coming? Read More › 10 Sep, 2020
4G Clinical Named to Fast Company’s Second Annual List Of The 100 Best Workplaces for Innovators 4G Clinical joins Google, Dell, Diageo, Alibaba, Etsy, Nestle, and many others. Read More › 29 Jul, 2020
5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare Read More › 29 May, 2020
.png)
.png)
.png)
.png)
.png)
